Research and Development

Showing 15 posts of 9600 posts found.

Contract research news in brief

December 12, 2012 Research and Development AMRI, Covance, Dimensione Ricerca, INC Research, Perceptive Informatics, TFS

TFS buys Italian CRO Dimensione Ricerca, AMRI closes a US facility plus business development updates from Covance, Perceptive Informatics and …

EC approves new Xaluprine formulation

December 12, 2012 Research and Development

The European Commission has approved a revised formulation of Xaluprine (mercaptopurine oral suspension) which no longer contains the preservative propyl …
Sanofi image

Working Life: Caroline Horwood

December 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Working Life

How did you find your way into your current role?Through an exciting and challenging route over 25 years! The key …

Circassia appoints new head to its Board of directors

December 6, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Jean-Jacques Garaud to its Board of directors. Garaud has extensive …
hans_008_4189455_rohde_hans

uniQure appoints Basilea’s chief commercial officer

December 6, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Basilea, uniQure

Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …
screen_shot_2012-12-05_at_10

ImmunoCellular appoints Andrew Gengos as chief executive

December 5, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Gengos, ImmunoCellular

Clinical stage firm ImmunoCellular Therapeutics has announced the appointment of Andrew Gengos as president and chief executive and member of …
Bayer image

New boost for drug candidates

December 5, 2012 Research and Development, Sales and Marketing Bayer, EFPIA, K4DD, Leiden

A new project is trying to increase the hit rates of successful drug candidates by improving the way they are …

Trajenta may reduce stroke damage

December 4, 2012 Research and Development, Sales and Marketing Boehringer, EMA, Trajenta, diabetes, linagliptin

Boehringer Ingelheim’s  diabetes drug Trajenta could one day be used to minimise the effects of brain damage following stroke. Scientists …

R&D costs rise ten-fold

December 4, 2012 Research and Development, Sales and Marketing OHE, R&D, research and development

Research by the Office of Health Economics (OHE) think tank shows that the cost of pharma R&D has risen ten-fold …

J&J’s Alex Gorsky to be chairman and chief executive

December 3, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Johnson & Johnson has has elected its chief executive Alex Gorsky to be its chairman of the Board of directors.  …
mr_subhanu_saxena__1276617e

New chief executive for Cipla

November 30, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Cipla, Subhanu Saxena

Indian pharma firm Cipla has announced the appointment of Novartis’ Subhanu Saxena as its chief executive. Saxena joins Cipla in …
Novartis image

Novartis R&D warning

November 29, 2012 Research and Development, Sales and Marketing NHS, Novartis. R&D, trials

Novartis has hit out at what it sees as the high cost of UK clinical trials, warning that business will …
screen_shot_2012-11-28_at_15

Genzyme appoints new GM for UK and Ireland

November 29, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brendan Martin, Genzyme

Genzyme has announced the appointment of Brendan Martin as general manager for UK and Ireland. Martin will be responsible for …

Survey: pharma losing $564 billion each year

November 28, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cap Gemini, Health Prize, pharma

Pharma companies are losing $564 billion each year – more than half the industry’s $956 billion revenue worldwide last year …
screen_shot_2012-11-27_at_13

RSA welcomes new starter

November 28, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huberts, rsa

Life Sciences Executive Search and Interim Management specialists RSA, has announced that Michael Huberts has joined the UK business as …
The Gateway to Local Adoption Series

Latest content